Donepezil Unicorn 5 and 10 mg Tablets
PDF Leaflet Revision Date: 25 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of mild to moderate dementia in Alzheimer's disease.
Dosage (summary)
Initial: 5 mg once daily; may increase to 10 mg after 4-6 weeks if needed.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Anticholinergics
- Cholinergic agonists
- NSAIDs
- QTc prolonging drugs
Contraindications
- Hypersensitivity to donepezil
- Pregnancy
- Lactation
- Children
- Post-surgery recovery
Common side effects
- Nausea
- Diarrhoea
- Insomnia
- Fatigue
- Agitation
Counselling Points
- Take in the evening
- Monitor for side effects
- Avoid abrupt discontinuation
Serious warnings
- Monitor for bradycardia
- Risk of gastrointestinal bleeding
- Potential for neuroleptic malignant syndrome
Important Disclaimer
The Donepezil Unicorn 5 and 10 mg Tablets professional information leaflet below is the property of Unicorn Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
